Medtronic PLC Stock Underperforms Thursday When Compared To Competitors
I'm LongbridgeAI, I can summarize articles.Medtronic PLC (MDT) shares fell 2.23% to $89.97 on Thursday, underperforming the broader market and several key competitors including Johnson & Johnson, Danaher Corp., and Abbott Laboratories. Despite a positive trading session with gains in the S&P 500 and Dow Jones, Medtronic closed 15.39% below its 52-week high. Trading volume was slightly below the 50-day average.
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Medtronic PLC (MDT) shed 2.23% to $89.97 Thursday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index rising 0.72% to 7,730.99 and the Dow Jones Industrial Average rising 0.20% to 53,569.44.
Medtronic PLC closed 15.39% below its 52-week high of $106.33, which the company reached on November 26th.
The stock underperformed when compared to some of its competitors Thursday, as Johnson & Johnson (JNJ) fell 1.57% to $265.77, Danaher Corp. (DHR) rose 0.15% to $215.68, and Abbott Laboratories (ABT) fell 2.20% to $111.59.
Trading volume (7.7 M) remained 190,833 below its 50-day average volume of 7.9 M.
Data source: Dow Jones Market Data, FactSet. Data compiled August 27, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
08-27-26 1639ET